EUVIMEDEUVIMED entdecken
Crossref

Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells

Qiuzhi Gao, Chao Huang, Ting Liu, Fumeng Yang, Zhihong Chen, Li Sun, Yuanyuan Zhao, Mei Wang iD, Liqi Luo, Chenglin Zhou, Wei Zhu iD

Journal of Cellular Biochemistry · 2024

DOI: 10.1002/jcb.30521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, 2024. Verfasst von Qiuzhi Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Stomach Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Jiangsu National Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite surgical treatment combined with multidrug therapy having made some progress, chemotherapy resistance is the main cause of recurrence and death of gastric cancer (GC). Gastric cancer mesenchymal stem cells (GCMSCs) have been reported to be correlated with the limited efficacy of chemotherapy in GC, but the mechanism of GCMSCs regulating GC resistance needs to be further studied. The gene set enrichment analysis (GSEA) was performed to explore the glycolysis‐related pathways heterogeneity across different cell subpopulations. Glucose uptake and lactate production assays were used to evaluate the importance of B7H3 expression in GCMSCs‐treated GC cells. The therapeutic efficacy of oxaliplatin (OXA) and paclitaxel (PTX) was determined using CCK‐8 and colony formation assays. Signaling pathways altered by GCMSCs‐CM were revealed by immunoblotting. The expression of TNF‐α in GCMSCs and bone marrow mesenchymal stem cells (BMMSCs) was detected by western blot analysis and qPCR. Our results showed that the OXA and PTX resistance of GC cells were significantly enhanced in the GCMSCs‐CM treated GC cells. Acquired OXA and PTX resistance was characterized by increased cell viability for OXA and PTX, the formation of cell colonies, and decreased levels of cell apoptosis, which were accompanied by reduced levels of cleaved caspase‐3 and Bax expression, and increased levels of Bcl‐2, HK2, MDR1, and B7H3 expression. Blocking TNF‐α in GCMSCs‐CM, B7H3 knockdown or the use of 2‐DG, a key enzyme inhibitor of glycolysis in GC cells suppressed the OXA and PTX resistance of GC cells that had been treated with GCMSCs‐CM. This study shows that GCMSCs‐CM derived TNF‐α could upregulate the expression of B7H3 of GC cells to promote tumor chemoresistance. Our results provide a new basis for the treatment of GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsStomach NeoplasmsHumansCell Line, TumorCell ProliferationDrug Resistance, NeoplasmDrug Therapy, CombinationGlycolysisLeprostatic AgentsOxaliplatinPaclitaxelTumor Necrosis Factor-alphaB7 Antigens

Stichwörter der Autor:innen

B7H3HK2MSCschemoresistancegastric cancer

Substanzen

Leprostatic AgentsOxaliplatinPaclitaxelTumor Necrosis Factor-alphaCD276 protein, humanB7 Antigens

Autor:innen und Institutionen

  • School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
  • Department of Laboratory Medicine, Lianyungang Clinical College of Jiangsu University, Lianyungang, Jiangsu, China.
  • Department of Gastrointestinal Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
  • Department of Clinical Laboratory, Affiliated Kunshan Hospital of Jiangsu University, Suzhou, Jiangsu, China.
  • Department of Laboratory Medicine, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, China.

ORCID-Profile: Mei Wang, Wei Zhu

Förderung

  • Jiangsu National Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Gao, Q., Huang, C., Liu, T., Yang, F., Chen, Z., Sun, L., Zhao, Y., Wang, M., Luo, L., Zhou, C., & Zhu, W. (2024). Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.30521

Vancouver

Gao Q, Huang C, Liu T, Yang F, Chen Z, Sun L, et al. Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells. Journal of Cellular Biochemistry. 2024. doi:10.1002/jcb.30521

BibTeX
@article{Gao2024,
  author = {Gao, Qiuzhi and Huang, Chao and Liu, Ting and Yang, Fumeng and Chen, Zhihong and Sun, Li and Zhao, Yuanyuan and Wang, Mei and Luo, Liqi and Zhou, Chenglin and Zhu, Wei},
  title = {Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells},
  journal = {Journal of Cellular Biochemistry},
  year = {2024},
  doi = {10.1002/jcb.30521}
}
Kostenlos starten →